Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Despite overcast weather a large crowd joined veterans and gathered around Dunkirk's memorial square to pay their respects.
A German 65-year-old teacher from Berlin has given birth to quadruplets after a pregnancy that was widely criticised because of her age.
Although there are bright skies for many as we start the bank holiday, more central, eastern and south eastern regions will be cloudy.